PURPOSE: Hypoxic conditions cause fibroblasts to differentiate into alpha smooth-muscle cell actin (α -SMA)-positive cells, i.e. myofibroblasts. This process is a hallmark of venous neointimal hyperplasia (VNH) associated with hemodialysis vascular access. The purpose of this study was to determine if blood outgrowth endothelial cells (BOEC) may reduce the conversion of fibroblasts into myofibroblasts under hypoxic conditions, and to determine the potential mechanisms involved. METHODS: An experimental model was used, in which fibroblasts and BOEC were subjected to hypoxia under contact and transwell conditions to determine if BOEC reduce the conversion of fibroblasts into myofibroblasts under hypoxic conditions. Gene expression under different conditions was performed. In addition, functional assays including cell proliferation and migration were determined. RESULTS: This study demonstrates that contact needs to occur between BOEC and fibroblasts for the reduction of the hypoxia-driven conversion of fibroblasts into α-SMA. This is associated with a decrease in several proangiogenic genes including vascular endothelial growth factor A, platelet-derived growth factor, fibroblast growth factor and matrix metalloproteinase 2 in fibroblasts in contact with BOEC when compared to fibroblasts alone. In addition, migration is significantly reduced while proliferation remains unchanged. CONCLUSION: This study helps provide rationale for using BOEC delivered to the adventitia of the outflow vein of hemodialysis vascular access to reduce VNH.
PURPOSE:Hypoxic conditions cause fibroblasts to differentiate into alpha smooth-muscle cell actin (α -SMA)-positive cells, i.e. myofibroblasts. This process is a hallmark of venous neointimal hyperplasia (VNH) associated with hemodialysis vascular access. The purpose of this study was to determine if blood outgrowth endothelial cells (BOEC) may reduce the conversion of fibroblasts into myofibroblasts under hypoxic conditions, and to determine the potential mechanisms involved. METHODS: An experimental model was used, in which fibroblasts and BOEC were subjected to hypoxia under contact and transwell conditions to determine if BOEC reduce the conversion of fibroblasts into myofibroblasts under hypoxic conditions. Gene expression under different conditions was performed. In addition, functional assays including cell proliferation and migration were determined. RESULTS: This study demonstrates that contact needs to occur between BOEC and fibroblasts for the reduction of the hypoxia-driven conversion of fibroblasts into α-SMA. This is associated with a decrease in several proangiogenic genes including vascular endothelial growth factor A, platelet-derived growth factor, fibroblast growth factor and matrix metalloproteinase 2 in fibroblasts in contact with BOEC when compared to fibroblasts alone. In addition, migration is significantly reduced while proliferation remains unchanged. CONCLUSION: This study helps provide rationale for using BOEC delivered to the adventitia of the outflow vein of hemodialysis vascular access to reduce VNH.
Authors: C Legrand; M Polette; J M Tournier; S de Bentzmann; E Huet; M Monteau; P Birembaut Journal: Exp Cell Res Date: 2001-04-01 Impact factor: 3.905
Authors: Allan J Collins; Bertram Kasiske; Charles Herzog; Shu-Cheng Chen; Susan Everson; Edward Constantini; Richard Grimm; Marshall McBean; Jay Xue; Blanche Chavers; Arthur Matas; Willard Manning; Thomas Louis; Wei Pan; Jiannong Liu; Suying Li; Tricia Roberts; Frederick Dalleska; Jon Snyder; James Ebben; Eric Frazier; Daniel Sheets; Roger Johnson; Shuling Li; Stephan Dunning; Delaney Berrini; Haifeng Guo; Craig Solid; Cheryl Arko; Frank Daniels; Xinyue Wang; Beth Forrest; David Gilbertson; Wendy St Peter; Pamela Frederick; Paul Eggers; Lawrence Agodoa Journal: Am J Kidney Dis Date: 2003-12 Impact factor: 8.860
Authors: P P G M Rooijens; J H M Tordoir; T Stijnen; J P J Burgmans; A A E A Smet de; T I Yo Journal: Eur J Vasc Endovasc Surg Date: 2004-12 Impact factor: 7.069
Authors: P Roy-Chaudhury; B S Kelly; M A Miller; A Reaves; J Armstrong; N Nanayakkara; S C Heffelfinger Journal: Kidney Int Date: 2001-06 Impact factor: 10.612
Authors: Joris I Rotmans; Evelyn Velema; Hence J M Verhagen; Jan D Blankensteijn; Dominique P V de Kleijn; Erik S G Stroes; Gerard Pasterkamp Journal: J Vasc Surg Date: 2004-02 Impact factor: 4.268
Authors: Rajiv Gulati; Dragan Jevremovic; Timothy E Peterson; Tyra A Witt; Laurel S Kleppe; Cheryl S Mueske; Amir Lerman; Richard G Vile; Robert D Simari Journal: Circulation Date: 2003-09-02 Impact factor: 29.690
Authors: Ameet K Piryani; Sreenivasulu Kilari; Edwin Takahashi; Randall R DeMartino; Jay Mandrekar; Allan B Dietz; Sanjay Misra Journal: Kidney360 Date: 2021-09-28